Taihe Capital
VC Fund
Beijing, China
Taihe Capital is an equity investment management company specializing in science and technology innovation.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 9%
Last updated:
For AI agents: llms.txt
Industries Taihe Capital invests in
MedicalHealth CareManufacturingArtificial IntelligenceApplication Specific Integrated Circuit (ASIC)
Stages Taihe Capital invests in
AngelSeries BSeries CSeedSeries A
Countries Taihe Capital invests in
ChinaUnited Kingdom
Investment Focus
Industry
- Medical 2 (18%)
- Health Care 2 (18%)
- Manufacturing 2 (18%)
- Artificial Intelligence 2 (18%)
- Application Specific Integrated Circuit (ASIC) 2 (18%)
Stage
- Angel 2 (18%)
- Series B 2 (18%)
- Series C 2 (18%)
- Seed 1 (9%)
- Series A 1 (9%)
Country
- China 8 (73%)
- United Kingdom 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Zhixin Microelectronics
|
Zhixinwei is a semiconductor device developer. It is an enterprise focusing on the R&D of third-generation semiconductor power devices | Series A / Dec 22, 2023 | |
Wanxietong Information Technology
|
Wanxietong Information Technology is a national high-tech company that provides integrated circuit design and chip-level solutions. | $13.7M / Venture - Series Unknown / Oct 12, 2023 | |
Unistarcom
|
Unistarcom is a company that produces core optical modules and subsystems in space laser communication and optical fiber sensing. | Angel / Feb 15, 2023 | |
|
Zhixin Microelectronics
|
Zhixinwei is a semiconductor device developer. It is an enterprise focusing on the R&D of third-generation semiconductor power devices | Angel / Feb 15, 2023 | |
Made by Data
|
Made by Data uses machine learning technology to solve the most challenging yet rewarding problems in the investment industry, including delivering alpha. Their data was fed into various deep learning and reinforcement learning models to infer and predict. | Seed / Jan 25, 2023 | |
|
Zhixin Microelectronics
|
Zhixinwei is a semiconductor device developer. It is an enterprise focusing on the R&D of third-generation semiconductor power devices | Angel / May 13, 2022 | |
Shiyue Daotian
|
Shiyue Daotian is an agricultural enterprise that provides an industrial chain integrating breeding, planting, processing, warehousing, and sales services. Their products include whole grains and meal replacement powder. They serve consumers. | $227.6M / Series B / May 31, 2021 | |
Burning Rock Biotech
|
Burning Rock focuses on providing individualized cancer treatment guidance for the patients. Using medical and bio informatics plus Next-Generation Sequencing (NGS) as the core technologies, the company is committed to offering one-stop solution for clinical and R&D services concerning the genetic testing of individualized cancer treatment.Established in March 2014, Burning Rock is headquartered in Beijing. Its first medical laboratory, "Guangzhou Burning Rock Medical Examination Institute Co., Ltd." is situated on Guangzhou International Bio Island which is blessed with a picturesque environment and rich in scientific research deposits. Later it established a R&D center in Shanghai. It occupies over 10,000 ㎡ in total. Burning Rock is committed to guiding the individualistic treatment of tumor patients, centered around NGS and biomedical informatics, with conventional tumor molecular pathology detection as the cornerstone, trying to build one-stop solutions for individualistic treatment clinical detection service and scientific research of tumor. | $120.5M / Series C / Feb 14, 2019 | |
Infervision
|
Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers. Beijing Infervision is an artificial intelligence high-tech company committed to applying deep learning technology to assist medical image diagnosis as efficient and accurate solutions. Infravision effectively uses various typesof medical data to create clinically valued products and promotes precision analysis in the medical field, especially in assisted image diagnosis. Based on years of research preparation, Infervision launched the world's first "Infervision - artificial intelligence precise healthcare platform", and is the first to release intelligent X-ray assisted diagnosis products and intelligent CT assisted diagnosis products. These products are already in trials at Shanghai Changzheng Hospital, Tongji Medical College of HUST in Wuhan, and Dalian Zhongshan Hospital. The company is also engaged in academic research and has established a deep cooperative relationship with top institutions in Chinese Radiology, combining both medical science and medical technology while laying a solid foundation for artificial intelligence breakthroughs in the medical field. Infervision has established cooperative business partnerships with close to 20 Tertiary Grade A hospitals including Peking Union Medical College Hospital, Shanghai Changzheng Hospital, Tongji Medical College of HUST in Wuhan, and Dalian Zhongshan Hospital, and has successfully broken the barriers between medical data, technology, and application scenarios, creating a unique system of an artificial intelligence computing platform and precise healthcare intelligence system. | Series C / Dec 10, 2018 | |
Zuoyebang
|
Zuoyebang is an online education startup that provides educational products and services to students in primary and high school.The platform that it offers is utilizing artificial intelligence which enables students to upload their homework questions and search for answers for their study-related problems. It is also providing online courses,live lessons, and homework help for kindergarten to 12th-grade students. Zuoyebang is backed by Chinese search firm Baidu as well as its investors which includes Alibaba Group, Tiger Global Management, SoftBank Vision Fund, Sequoia Capital China, and FountainVest Partners.Hou Jianbin founded the company in Beijing, Beijing, China in 2014. | $350M / Series D / Jul 18, 2018 | |
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
SaaS Investors
99,274 investors
Health Care Investors
43,014 investors
Artificial intelligence Investors
40,702 investors
Climate Investors
40,325 investors
Hardware Investors
40,144 investors
Manufacturing Investors
24,696 investors
Medical Investors
18,848 investors
SaaS VC Funds
61,208 investors
Health Care VC Funds
32,370 investors
FAQ
What does Taihe Capital invest in?
Taihe Capital invests primarily in Medical, Health Care and Manufacturing startups, most often at Angel and Series B stage. Most of the 11 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Taihe Capital last invest?
The most recent investment recorded for Taihe Capital closed in Dec 2023. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
